{
    "2019-12-12": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Novartis (NVS) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Novartis",
                        "AbbVie",
                        "Sanofi",
                        "Pioneer Natural Resources",
                        "Aqua America"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "energy",
                        "utilities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Gilead Teams Up With Kiniksa, Submits BLA for CAR T Therapy",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Kiniksa",
                        "BLA",
                        "CAR T Therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}